ArriVent BioPharma, Inc. (NASDAQ:AVBP) Receives $39.00 Average Price Target from Analysts
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) have been given an average rating of “Buy” by the six brokerages that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […]
Shares of ArriVent BioPharma, Inc. (NASDAQ:AVBP – Get Free Report) have been given an average rating of “Buy” by the six brokerages that are covering the stock, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1-year […]
